Your session is about to expire
← Back to Search
Benzodiazepine
Diazepam for Alcohol Withdrawal Syndrome
N/A
Waitlist Available
Led By Matthew Sloan, MD, MSc
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-5 day treatment period
Awards & highlights
No Placebo-Only Group
Summary
This trial uses telemedicine to help people manage alcohol withdrawal symptoms from home. It targets individuals who are actively drinking and have a history of withdrawal. Doctors monitor symptoms via video calls and provide medication based on the severity of the symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-5 day treatment period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-5 day treatment period
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Retention in treatment
Transfer to a higher level of care
Secondary study objectives
Diazepam dose
Duration of active withdrawal treatment
Patient satisfaction with the telemedicine platform
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Symptom-triggered diazepam treatmentExperimental Treatment1 Intervention
Participants will be treated for a period of 3 days using a symptom-triggered withdrawal management protocol delivered over telemedicine. Participants who score 10 or above on the modified CIWA-Ar will be advised to take a specific dose of diazepam (either 10 or 20mg, at the clinician's discretion). Participants will be reassessed regularly over the 3-day period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diazepam
2016
Completed Phase 4
~2800
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,527,436 Total Patients Enrolled
Centre for Addiction and Mental HealthLead Sponsor
375 Previous Clinical Trials
82,857 Total Patients Enrolled
Ontario Ministry of Health and Long Term CareOTHER_GOV
91 Previous Clinical Trials
107,994 Total Patients Enrolled
Matthew Sloan, MD, MScPrincipal InvestigatorCentre for Addiction and Mental Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Symptom-triggered diazepam treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.